COVID-19 Vaccine Uptake Among People Living with HIV.

Tim W Menza,Lea Bush,Amy I Zlot,Michelle Barber,Jeff Capizzi

doi:10.1007/s10461-021-03570-9

Tim W Menza, Lea Bush + Show 3 more

Open Access

https://doi.org/10.1007/s10461-021-03570-9

Copy DOI

Abstract

People living with HIV (PLWH) are at greater risk for severe COVID-19 and are a priority population for COVID-19 vaccination. As of June 15, 2021, 61.6% of PLWH in Oregon received ≥ 1 COVID-19 vaccine dose. Younger PLWH, Hispanic/Latinx PLWH and PLWH who inject drugs or reside in rural and frontier areas had low vaccine uptake while PLWH who were engaged in care, enrolled in the AIDS Drug Assistance Program, and vaccinated against influenza had high vaccine uptake. Greater advocacy, education, and care navigation are required to increase COVID-19 vaccine access and uptake among PLWH.Supplementary InformationThe online version contains supplementary material available at 10.1007/s10461-021-03570-9.

Highlights

Mounting evidence indicates that people living with HIV (PLWH) are at higher risk of severe COVID-19 [1]
While COVID-19 hospitalizations are increasing among younger adults [9], COVID-19 vaccination uptake was lowest among PLWH 18–29 years old
PLWH of color overall, and Hispanic/Latinx PLWH in particular, were less likely to be vaccinated compared to white PLWH

Summary

Introduction

Mounting evidence indicates that people living with HIV (PLWH) are at higher risk of severe COVID-19 [1]. More than 50% of PLWH in Oregon and the United States are over age 50 [3]. PLWH are more likely to experience comorbid medical conditions and experience them at a younger age compared to those without HIV [4]. PLWH are more likely to experience social and economic disadvantage than those without HIV [5] and this disadvantage is associated with a greater risk of COVID-19 [6]. HIV is more common among Black, Hispanic/Latinx, Indigenous and LGBTQ + communities all of whom have shouldered the burden of the COVID-19 pandemic in Oregon and across the United States [7, 8]. The increased risk of severe COVID-19 makes access to and

Methods

Results

Discussion